GoodRx cuts guidance

 Guidance

For the fourth quarter and full year 2024, management is anticipating the following:

$ in millions	4Q 2024	4Q 2023	YoY Change
Revenue1	~$200	$196.6	~2%
Adjusted Revenue1	~$200	$196.6	~2%
Adjusted EBITDA Margin3	~34%	29.1%	~490 bps
$ in millions	FY 2024	FY 2023	YoY Change
Revenue1	~$794	$750.3	~6%
Adjusted Revenue1	~$794	$760.3	~4%
Adjusted EBITDA3	$255 - $260	$217.4	17% - 20%

“For the fourth quarter of 2024, we are guiding to revenue and Adjusted Revenue of approximately $200 million and Adjusted EBITDA Margin of about 34%,” said Karsten Voermann, Chief Financial Officer. “While our full year 2024 revenue and Adjusted Revenue expectations are lower than what we previously indicated, we are confident we can achieve strong Adjusted EBITDA of $255 to $260 million, up over 17% from 2023, and Adjusted EBITDA Margin of over 32%, up more than 340 basis points from 2023.”

“Our balance sheet and liquidity remained robust in the third quarter of 2024. Our capital allocation priorities are unchanged and we will continue to prioritize high return investments and maximizing value for shareholders,” concluded Voermann.

Investor Conference Call and Webcast

GoodRx management will host a conference call and webcast today, November 7, 2024, at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook.

To access the conference call, please pre-register using the following link:

https://register.vevent.com/register/BIe2e0d2e5ebec4cc3ae9f66e59492a2f5

Registrants will receive a confirmation with dial-in details and a unique passcode required to join.

The call will also be webcast live on the Company’s investor relations website at https://investors.goodrx.com, where accompanying materials will be posted prior to the conference call.

Approximately one hour after completion of the live call, an archived version of the webcast will be available on the Company’s investor relations website at https://investors.goodrx.com for at least 30 days.

https://www.businesswire.com/news/home/20241107081396/en